Award
National Cancer Institute 3R01CA286069-02S1
Using gene expression to identify patients at high risk for late breast cancer recurrence
Recipient
Not specified
Award Amount
$204,071.00
Ceiling
$204,071.00
Awarded
September 18, 2024
Identifier
3R01CA286069-02S1
NIH grant awarded by the National Cancer Institute to develop gene expression profiles for predicting late breast cancer recurrence risk using machine learning and biological pathway analysis.
Description
This is a NIH grant project focused on developing a gene expression profile to predict late breast cancer recurrence risk, involving advanced machine learning models and biological pathway analysis.